Mitsubishi Tanabe Pharma Overview
Company Headquarters: Japan
Founded: 1678
Workforce: ~ 69,784
Revenue: USD 34.64 Billion
Company Working: Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures, and commercializes ethical drugs and over the counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, diabetes, kidney diseases, central nervous system (CNS) disorders, and others. It also develops vaccines for preventing various infectious diseases. Mitsubishi Tanabe also offers major products for skin conditions and digestive medicines. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe, and North America. Mitsubishi Tanabe is headquartered in Osaka, Japan.
Strategy
Mitsubishi Tanabe Pharma Corporation is a Japanese pharmaceutical company that focuses on the research, development, and commercialization of pharmaceuticals and medical devices. The company's strategy includes the following:
Research and Development: Mitsubishi Tanabe Pharma Corporation invests heavily in research and development to discover new drugs and medical devices. The company's R&D efforts focus on developing innovative drugs to address unmet medical needs in areas such as neurology, oncology, and immunology.Strategic Partnerships: Mitsubishi Tanabe Pharma Corporation has established partnerships with leading research institutions and pharmaceutical companies worldwide. These partnerships help the company to expand its research capabilities, access new technologies, and strengthen its pipeline of drugs and medical devices.Global Expansion: Mitsubishi Tanabe Pharma Corporation is expanding its global footprint through partnerships, acquisitions, and strategic investments. The company is focused on increasing its presence in key markets such as the United States and Europe, where it sees significant growth opportunities.Patient-Centered Approach: Mitsubishi Tanabe Pharma Corporation places a strong emphasis on patient-centricity, which means putting patients at the center of everything they do. The company's goal is to develop drugs and medical devices that meet the specific needs of patients and improve their quality of life.
